Publications by authors named "Boddu Mrunalini"

Claim this Profile
B
Bone-Marrow-Targeted Nanocomposite Abrogates C-Myb-Survivin Cross Talk in MLL-AF9-Rearranged Acute Myeloid Leukemia in and Patient-Derived Xenograft Models.
Avinash Chandra Kushwaha, Boddu Mrunalini, Pankaj Malhotra, Surajit Karmakar, Subhasree Roy Choudhury

ACS Appl Mater Interfaces· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD56-targeted genetic engineering of natural killer cells mediates immunotherapy for acute myeloid leukemia.
Avinash Chandra Kushwaha, Boddu Mrunalini, Pankaj Malhotra, Subhasree Roy Choudhury

Nanoscale· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Encapsulation of 4-oxo--(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models.
Boddu Mrunalini, Atul Dev, Avinash Chandra Kushwaha, Mohammed Nadim Sardoiwala, Surajit Karmakar

Nanoscale· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FTY720 Nanoformulation Induces O-GlcNacylation of Synuclein to Alleviate Synucleinopathy.
Mohammed Nadim Sardoiwala, Mrunalini Boddu, Liku Biswal, Surajit Karmakar, Subhasree Roy Choudhury

ACS Chem Neurosci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis